Table 1.
PVE (n = 27) | ALPPS (n = 2) | |
---|---|---|
Age (years) | Median 69 | Median 68 |
Gender (male) | 19 (70%) | 0 (0%) |
Diagnosis | ||
CRLM | 5 (19%) | 2 (100%) |
Cholangiocarcinoma | 10 (37%) | 0 (0%) |
HCC | 9 (33%) | 0 (0%) |
Others | 3 (11%) | 0 (0%) |
Surgical procedure | ||
Hr1 | 1 (4%) | 0 (0%) |
Hr2 | 22 (81%) | 0 (0%) |
Hr3 | 4 (15%) | 0 (0%) |
ALPPS | 0 | 2 (100%) |
with PPPD | 2 (7%) | 0 (0%) |
with bile-duct reconstruction | 10 (37%) | 0 (0%) |
with vascular reconstruction | 5 (19%) | 0 (0%) |
Liver failure | 2 (7%) | 0 (0%) |
90 day mortality | 0 (0%) | 0 (0%) |
CRLM Colorectal liver metastasis, HCC Hepatocellular carcinoma, PPPD Pylorus-preserving pancreaticoduodenectomy